Trinity Biotech | TRIB - Interest Expense On Debt


Trinity Biotech reported $3.33M in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
Abbott USD 42M 2M Dec/2025
Bayer EUR 762M 267M Sep/2025
Bio-Rad Laboratories USD 12.3M 100K Sep/2025
EDAP TMS EUR 49K 8K Sep/2025
J&J USD 18M 290M Sep/2025
Mesa Laboratories USD 3.02M 180K Sep/2024
OraSure Technologies 2.91M 130K Dec/2024
Roche Holding CHF 304M 7.5M Jun/2025
Siemens EUR 435M 1000K Dec/2025
Surmodics USD 884K 5K Sep/2024
Thermo Fisher Scientific USD 365M 18M Dec/2025
Tosoh JPY 884M 65M Sep/2025
Trinity Biotech USD 3.33M 50K Sep/2025
Veracyte USD 2K 1000 Dec/2023